TICKERNOMICS Sign up
Last Update: 2023-12-23 06:06:27
Sernova Corp ( SVA.TO ) https://www.sernova.com
0.51USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
Canada
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-12.56%
SVA.TO
SPY
30.72%
SVA.TO
42.42%
SPY
112.82%
SVA.TO
265.84%
SPY
201.04%
SVA.TO
318.52%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
154.76
144.87
0.18
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-5.84
0.00
8.79
-10.73
0.00
-5.05
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
10.4012
-165.66
-114.84
1.58
Other Earnings and Cash Flow Stats:
Sernova Corp ( SVA.TO ) Net Income TTM ($MM) is -28.80
Sernova Corp ( SVA.TO ) Operating Income TTM ($MM) is -29.65
Sernova Corp ( SVA.TO ) Owners' Earnings Annual ($MM) is 0.00
Sernova Corp ( SVA.TO ) Current Price to Owners' Earnings ratio is 0.00
Sernova Corp ( SVA.TO ) EBITDA TTM ($MM) is -29.33
Sernova Corp ( SVA.TO ) EBITDA Margin is 0.00%
Capital Allocation:
Sernova Corp ( SVA.TO ) has paid 0.00 dividends per share and bought back -29.739547 million shares in the past 12 months
Sernova Corp ( SVA.TO ) has reduced its debt by 0.26157529658781 million USD in the last 12 months
Capital Structure:
Sernova Corp ( SVA.TO ) Interest-bearing Debt ($MM) as of last quarter is 0
Sernova Corp ( SVA.TO ) Annual Working Capital Investments ($MM) are 0
Sernova Corp ( SVA.TO ) Book Value ($MM) as of last quarter is 17
Sernova Corp ( SVA.TO ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
Sernova Corp ( SVA.TO ) has 13 million in cash on hand as of last quarter
Sernova Corp ( SVA.TO ) has 7 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Sernova Corp ( SVA.TO ) has 303 common shares outstanding as of last quarter
Sernova Corp ( SVA.TO ) has 0 million USD of preferred stock value
Academic Scores:
Sernova Corp ( SVA.TO ) Altman Z-Score is 4.85 as of last quarter
Sernova Corp ( SVA.TO ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Sernova Corp ( SVA.TO ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Sernova Corp ( SVA.TO ) for the amount of $ on
11.01% of Sernova Corp ( SVA.TO ) is held by insiders, and 0.04% is held by institutions
Sernova Corp ( SVA.TO ) went public on 1970-01-01
Other Sernova Corp ( SVA.TO ) financial metrics:
FCF:-16.60
Unlevered Free Cash Flow:0.00
EPS:-0.10
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-166.20
Beta:1.58
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Sernova Corp ( SVA.TO ) :
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.